Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1721-93-3

Post Buying Request

1721-93-3 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1721-93-3 Usage

Description

1-Methylisoquinoline is an organic compound belonging to the isoquinoline family. It is a yellow to light yellow liquid and is widely recognized for its utility as a research chemical compound. This versatile molecule is known for its unique chemical properties and potential applications across various industries.

Uses

Used in Research and Development:
1-Methylisoquinoline is used as a research chemical compound for [application reason] in the field of chemical research and development. Its unique properties make it a valuable tool for scientists and researchers working on the synthesis and study of novel compounds and materials.
Used in Pharmaceutical Industry:
1-Methylisoquinoline is used as an intermediate or building block for [application reason] in the pharmaceutical industry. Its chemical structure allows for the development of new drugs and therapeutic agents, potentially leading to breakthroughs in the treatment of various diseases and medical conditions.
Used in Chemical Synthesis:
1-Methylisoquinoline is used as a synthetic building block for [application reason] in the chemical synthesis of various organic compounds. Its reactivity and structural features make it a valuable component in the creation of complex molecules and advanced materials.
Used in Material Science:
1-Methylisoquinoline is used as a component in the development of new materials for [application reason] in the field of material science. Its unique properties may contribute to the creation of advanced materials with specific characteristics, such as improved conductivity, strength, or stability.

Synthesis Reference(s)

Journal of the American Chemical Society, 78, p. 6055, 1956 DOI: 10.1021/ja01604a029Organic Syntheses, Coll. Vol. 4, p. 641, 1963

Check Digit Verification of cas no

The CAS Registry Mumber 1721-93-3 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,7,2 and 1 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1721-93:
(6*1)+(5*7)+(4*2)+(3*1)+(2*9)+(1*3)=73
73 % 10 = 3
So 1721-93-3 is a valid CAS Registry Number.
InChI:InChI=1/C10H9N/c1-8-10-5-3-2-4-9(10)6-7-11-8/h2-7H,1H3

1721-93-3 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Alfa Aesar

  • (H27029)  1-Methylisoquinoline, 97%   

  • 1721-93-3

  • 1g

  • 338.0CNY

  • Detail
  • Alfa Aesar

  • (H27029)  1-Methylisoquinoline, 97%   

  • 1721-93-3

  • 5g

  • 1387.0CNY

  • Detail
  • Aldrich

  • (264938)  1-Methylisoquinoline  97%

  • 1721-93-3

  • 264938-1G

  • 361.53CNY

  • Detail

1721-93-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 10, 2017

Revision Date: Aug 10, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-Methylisoquinoline

1.2 Other means of identification

Product number -
Other names 1-METHYLISOQUINOLINE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:1721-93-3 SDS

1721-93-3Relevant articles and documents

Enantioselective addition of organolithium reagents on isoquinoline

Alexakis, Alexandre,Amiot, Franck

, p. 2117 - 2122 (2002)

1-Methyl-1,2-dihydroisoquinoline and 1-butyl-1,2-dihydroisoquinoline were obtained by enantioselective addition of organolithium reagents on the isoquinoline. (-)-Sparteine was used as an external catalytic chiral ligand and an enantiomeric excess of 57%

-

Nozaki et al.

, p. 1123 (1966)

-

Isoquinoline thiosemicarbazone displays potent anticancer activity with: In vivo efficacy against aggressive leukemias

Sun, Daniel L.,Poddar, Soumya,Sun, Daniel L.,Pan, Roy D.,Poddar, Soumya,Rosser, Ethan W.,Pan, Roy D.,Abt, Evan R.,Rosser, Ethan W.,Van Valkenburgh, Juno,Abt, Evan R.,Le, Thuc M.,Van Valkenburgh, Juno,Lok, Vincent,Le, Thuc M.,Song, Janet,Li, Joanna,Hernandez, Selena P.,Mona, Christine E.,Stuparu, Andreea D.,Czernin, Johannes,Turlik, Aneta,Donahue, Timothy R.,Chen, Xiaohong,Radu, Caius G.,Cheng, Chi-An,Hernandez, Selena P.,Chen, Wei,Mona, Christine E.,Stuparu, Andreea D.,Vergnes, Laurent,Reue, Karen,Damoiseaux, Robert,Zink, Jeffrey I.,Czernin, Johannes,Donahue, Timothy R.,Houk, Kendall N.,Jung, Michael E.,Radu, Caius G.

, p. 392 - 410 (2020)

A potent class of isoquinoline-based Α-N-heterocyclic carboxaldehyde thiosemicarbazone (HCT) compounds has been rediscovered; based upon this scaffold, three series of antiproliferative agents were synthesized through iterative rounds of methylation and fluorination modifications, with anticancer activities being potentiated by physiologically relevant levels of copper. The lead compound, HCT-13, was highly potent against a panel of pancreatic, small cell lung carcinoma, prostate cancer, and leukemia models, with IC50 values in the low-to-mid nanomolar range. Density functional theory (DFT) calculations showed that fluorination at the 6-position of HCT-13 was beneficial for ligand-copper complex formation, stability, and ease of metal-center reduction. Through a chemical genomics screen, we identify DNA damage response/replication stress response (DDR/RSR) pathways, specifically those mediated by ataxia-telangiectasia and Rad3-related protein kinase (ATR), as potential compensatory mechanism(s) of action following HCT-13 treatment. We further show that the cytotoxicity of HCT-13 is copper-dependent, that it promotes mitochondrial electron transport chain (mtETC) dysfunction, induces production of reactive oxygen species (ROS), and selectively depletes guanosine nucleotide pools. Lastly, we identify metabolic hallmarks for therapeutic target stratification and demonstrate the in vivo efficacy of HCT-13 against aggressive models of acute leukemias in mice.

-

Barrows,Lindwall

, p. 2430 (1942)

-

Synthesis of novel functionalized 5-nitroisoquinolines and evaluation of in vitro antimalarial activity

Rathelot,Vanelle,Gasquet,Delmas,Crozet,Timon-David,Maldonado

, p. 503 - 508 (1995)

Novel aldimine and hydrazone isoquinoline derivatives were obtained after subjecting 1-formyl-5-nitroisoquinoline to classical reactions. Some of these compounds were found to have activity against a chloroquine-resistant Plasmodium falciparum strain (ACC Niger).

1,4-Dehydrochlorination of 1-(1-haloalkyl)-3,4-dihydroisoquinolines as a convenient route to functionalized isoquinolines

Jacobs, Jan,Van, Tuyen Nguyen,Stevens, Christian V.,Markusse, Peter,De Cooman, Paul,Maat, Leendert,De Kimpe, Norbert

, p. 3698 - 3701 (2009)

1-Chloroalkyl-, 1-(2,2-dichloroalkyl)-, and 1-(trichloromethyl)-3,4-dihydroisoquinolines are synthesized by chlorination of 1-alkyl-3,4-dihydroisoquinolines with N-chlorosuccinimide. These novel chlorinated 3,4-dihydroisoquinolines are suitable precursors for functionalized isoquinolines by aromatization involving sequential 1,4-dehydrochlorination, tautomerization, and nucleophilic substitution.

A ortho position alkylation method of organic compound containg pyridine

-

Paragraph 0108-0116, (2020/12/05)

A process for introducing alkyl at ortho positions of organic compounds containing pyridine. The method is not affected by the kind of substituent bonded to the pyridine and can be alkylated with high positional selectivity and high yield at N-based ortho-position of pyridine without being affected by the kind of substituent introduced to pyridine ortho position (pyridine N-based) can be advantageously used for the preparation of a compound containing an alkyl-introduced pyridine structure.

A Visible-Light Promoted Amine Oxidation Catalyzed by a Cp*Ir Complex

Davis, Holly Jane,H?ussinger, Daniel,Ward, Thomas R.,Okamoto, Yasunori

, p. 4512 - 4516 (2020/07/27)

Through a rapid screening of Cp*Ir complexes based on a turn-on type fluorescence readout, a [Cp*Ir(dipyrido[3,2-a : 2’,3’-c]phenazine)Cl]+ complex was found to catalyze the blue-light promoted dehydrogenation of N-heterocycles under physiological conditions. In the dehydrogenation of tetrahydroisoquinolines, the catalyst preferentially yielded the monodehydrogenated product, accompanying H2O2 generation. We surmise that this mechanism may be reminiscent of flavin-dependent oxidases.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1721-93-3